BACKGROUND: The mechanisms underlying speech abnormalities in Parkinson's disease (PD) remain poorly understood, with most of the available evidence based on male patients. This study aimed to estimate the occurrence and characteristics of speech disorder in early, drug-naive PD patients with relation to gender and dopamine transporter imaging. METHODS: Speech samples from 60 male and 40 female de novo PD patients as well as 60 male and 40 female age-matched healthy controls were analyzed. Quantitative acoustic vocal assessment of 10 distinct speech dimensions related to phonation, articulation, prosody, and speech timing was performed. All patients were evaluated using [123]I-2b-carbomethoxy-3b-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single-photon emission computed tomography and Montreal Cognitive Assessment. RESULTS: The prevalence of speech abnormalities in the de novo PD cohort was 56% for male and 65% for female patients, mainly manifested with monopitch, monoloudness, and articulatory decay. Automated speech analysis enabled discrimination between PD and controls with an area under the curve of 0.86 in men and 0.93 in women. No gender-specific speech dysfunction in de novo PD was found. Regardless of disease status, females generally showed better performance in voice quality, consonant articulation, and pauses production than males, who were better only in loudness variability. The extent of monopitch was correlated to nigro-putaminal dopaminergic loss in men (r = 0.39, p = 0.003) and the severity of imprecise consonants was related to cognitive deficits in women (r = -0.44, p = 0.005). CONCLUSIONS: Speech abnormalities represent a frequent and early marker of motor abnormalities in PD. Despite some gender differences, our findings demonstrate that speech difficulties are associated with nigro-putaminal dopaminergic deficits.

1st Faculty of Medicine Institute of Nuclear Medicine Charles University and General University Hospital Prague Czechia

Department of Circuit Theory Faculty of Electrical Engineering Czech Technical University Prague Prague Czechia

Department of Neurology and Centre of Clinical Neuroscience 1st Faculty of Medicine Charles University and General University Hospital Prague Czechia

Zobrazit více v PubMed

Poewe W, Seppi K, Tanner CM, et al. Parkinson disease. Nat Rev Dis Primers. 2017;23:17013.

Cerri S, Mus L, Blandini F. Parkinson's disease in women and men: what's the difference? J Parkinsons Dis. 2019;9:501-515.

Hirsch L, Jette N, Frolkis A, Steeves T, Pringsheim T. The incidence of Parkinson's disease: a systematic review and meta-analysis. Neuroepidemiology. 2016;46:292-300.

Dahodwala N, Shah K, He Y, et al. Sex disparities in access to caregiving in Parkinson disease. Neurology. 2018;90:e48-e54.

Szewczyk-Krolikowski K, Tomlinson P, Nithi K, et al. The influence of age and gender on motor and non-motor features of early Parkinson's disease: initial findings from the Oxford Parkinson Disease Center (OPDC) discovery cohort. Parkinsonism Relat Disord. 2014;20:99-105.

Hollien H. Vocal pitch variation related to vocal fold length. J Speech Hear Res. 1960;3:150-156.

Logemann JA, Fisher HB, Boshes B, Blonsky ER. Frequency and cooccurrence of vocal tract dysfunction in the speech of a large sample of Parkinson patients. J Speech Hear Disord. 1978;43:47-57.

Ho AK, Iansek R, Marigliani C, Bradshaw JL, Gates S. Speech impairment in a large sample of patients with Parkinson's disease. Behav Neurol. 1998;11:131-137.

Darley FL, Aronson AE, Brown JR. Differential diagnostic patterns of dysarthria. J Speech Hear Res. 1969;12:246-269.

Skodda S, Visser W, Schlegel U. Gender related patterns of dysprosody in Parkinson's disease and correlation between speech variables and motor symptoms. J Voice. 2011;25:76-82.

Hertrich I, Ackermann H. Gender-specific vocal dysfunction in Parkinson's disease: electroglottographic and acoustic analyses. Ann Otol Rhinol Laryngol. 1995;104:197-202.

Sapir S, Pawlas AA, Ramig LO, et al. Voice and speech abnormalities in Parkinson disease: relation to severity of motor impairment, duration of disease, medication, depression, gender, and age. J Med Speech Lang Pathol. 2001;9:213-226.

Suphinnapong P, Phokaewvarangkul O, Thubthong N, et al. Objective vowel sound characteristics and their relationship with motor dysfunction in Asian Parkinson's disease patients. J Neurol Sci. 2021;426:117487.

Pinto S, Ozsancak C, Tripoliti E, Thobois S, Limousin-Dowsey P, Auzou P. Treatments for dysarthria in Parkinson's disease. Lancet Neurol. 2004;3:547-556.

Picillo M, Palladino R, Moccia M, et al. Gender and non-motor fluctuations in Parkinson's disease: a prospective study. Parkinsonism Relat Disord. 2016;27:89-92.

Rusz J, Cmejla R, Ruzickova H, Ruzicka E. Quantitative acoustic measurements for characterization of speech and voice disorders in early untreated Parkinson's disease. J Acoust Soc Am. 2011;129:350-367.

Rusz J, Hlavnicka J, Tykalova T, et al. Smartphone allows capture of speech abnormalities associated with high risk of developing Parkinson's disease. IEEE Trans Neural Syst Rehabil Eng. 2018;26:1495-1507.

Dušek P, Bezdíček O, Brožová H, et al. Clinical characteristics of newly diagnosed Parkinson's disease patients included in the longitudinal BIO-PD study. Cesk Slov Neurol Neurochir. 2020;83(116):633-639.

Postuma RB, Berg D, Stern M, et al. MDS clinical diagnostic criteria for Parkinson's disease. Mov Disord. 2015;30:1591-1601.

Goetz CG, Fahn S, Martinez-Martin P, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): process, format, and clinimetric testing plan. Mov Disord. 2007;22:41-47.

Nasreddine ZS, Phillips NA, Bedirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695-699.

Darcourt J, Booij J, Tatsch K, et al. EANM procedure guidelines for brain neurotransmission SPECT using (123)I-labelled dopamine transporter ligands, version 2. Eur J Nucl Med Mol Imaging. 2010;37:443-450.

Dusek P, Ibarburu V, Bezdicek O, et al. Relations of non-motor symptoms and dopamine transporter binding in REM sleep behavior disorder. Sci Rep. 2019;9:1546.

Calvini P, Rodriguez G, Inguglia F, Mignone A, Guerra UP, Nobili F. The basal ganglia matching tools package for striatal uptake semi-quantification: description and validation. Eur J Nucl Med Mol Imaging. 2007;34:1240-1253.

Duffy JR. Motor Speech Disorders: Substrates, Differential Diagnosis and Management, 4th ed. Mosby; 2019.

Rusz J, Tykalova T, Ramig LO, Tripoliti E. Guidelines for speech recording and acoustic analyses in dysarthrias of movement disorders. Mov Disord. 2021;36:803-814.

Rusz J, Hlavnicka J, Novotny M, et al. Speech biomarkers in REM sleep behaviour disorder and Parkinson's disease. Ann Neurol. 2021;90:62-75.

Hlavnicka J. Automated analysis of speech disorders in neurodegenerative diseases. Ph.D. Thesis, Faculty of Electrical Engineering, Czech Technical University; 2018.

Hlavnicka J, Cmejla R, Tykalova T, Sonka K, Ruzicka E, Rusz J. Automated analysis of connected speech reveals early biomarkers of Parkinson's disease in patients with rapid eye movement sleep behaviour disorder. Sci Rep. 2017;7:12.

Hlavnicka J, Cmejla R, Klempir J, Ruzicka E, Rusz J. Acoustic tracking of pitch, modal and subharmonic vibrations of vocal folds in Parkinson's disease and Parkinsonism. IEEE Access. 2019;7:150339-150354.

Tripoliti E, Zrinzo L, Martinez-Torres I, et al. Effects of subthalamic stimulation on speech of consecutive patients with Parkinson disease. Neurology. 2011;76:80-86.

Skodda S, Gronheit W, Mancinelli N, Schlegel U. Progression of voice and speech impairment in the course of Parkinson's disease: a longitudinal study. Parkinsons Dis. 2013;2013:389195.

Delval A, Rambour M, Tard C, et al. Freezing/festination during motor tasks in early-stage Parkinson's disease: a prospective study. Mov Disord. 2016;31:1837-1845.

Rusz J, Hlavnicka J, Cmejla R, Ruzicka E. Automatic evaluation of speech rhythm instability and acceleration in dysarthrias associated with basal ganglia dysfunction. Front Bioeng Biotechnol. 2015;3:104.

Nadeau SE, Crosson B. Subcortical aphasia. Brain Lang. 1997;58:355-402.

Manes JL, Tjaden K, Parrish T, et al. Altered resting-state functional connectivity of the putamen and internal globus pallidus is related to speech impairment in Parkinson's disease. Brain Behav. 2018;8:e01073.

Selikhova M, Tripoliti E, Fedoryshyn L, et al. Analysis of a distinct speech disorder seen in chronic manganese toxicity following Ephedrone abuse. Clin Neurol Neurosurg. 2016;147:71-77.

Rossi C, Frosini D, Volterrani D, et al. Differences in nigro-striatal impairment in clinical variants of early Parkinson's disease: evidence from a FP-CIT SPECT study. Eur J Neurol. 2010;17:626-630.

Polychronis S, Niccolini F, Pagano G, Yousaf T, Politis M. Speech difficulties in early de novo patients with Parkinson's disease. Parkinsonism Relat Disord. 2019;64:256-261.

Lieberman P, Kako E, Friedman J, Tajchman G, Feldman LS, Jiminez EB. Speech production, syntax comprehension, and cognitive deficits in Parkinson's disease. Brain Lang. 1992;43:169-189.

Thies T, Mücke D, Lowit A, Kalbe E, Steffen J, Barbe MT. Prominence marking in parkinsonian speech and its correlation with motor performance and cognitive abilities. Neuropsychologia. 2020;137:107306.

Kent RD, Rosen K. Motor control perspectives on motor speech disorders. In: Maassen B, Kent R, Peters H, Lieshout PV, Hulstijn W, eds. Speech Motor Control in Normal and Disordered Speech. Oxford University Press; 2004:285-311.

Arnold C, Gehrig J, Gispert S, Seifried C, Kell CA. Pathomechanisms and compensatory efforts related to Parkinsonian speech. Neuroimage Clin. 2013;4:82-97.

Kaasinen V, Joutsa J, Noponen T, Johansson J, Seppänen M. Effects of aging and gender on striatal and extrastriatal [123I]FP-CIT binding in Parkinson's disease. Neurobiol Aging. 2015;36:1757-1763.

Grönholm EO, Roll MC, Horne MA, Sundgren PC, Lindgren AG. Predominance of caudate nucleus lesions in acute ischaemic stroke patients with impairment in language and speech. Eur J Neurol. 2016;23:148-153.

Gorris C, Ricci Maccarini A, Vanoni F, et al. Acoustic analysis of normal voice patterns in Italian adults by using Praat. J Voice. 2020;34:961.e9-961.e18.

Li F. The effect of speakers' sex on voice onset time in Mandarin stops. J Acoust Soc Am. 2013;133:EL142-EL147.

Tjaden K, Wilding GE. Rate and loudness manipulations in dysarthria: acoustic and perceptual findings. J Speech Lang Hear Res. 2004;47:766-783.

Rusz J, Tykalová T, Klempíř J, Čmejla R, Růžička E. Effects of dopaminergic replacement therapy on motor speech disorders in Parkinson's disease: longitudinal follow-up study on previously untreated patients. J Neural Transm. 2016;123:379-387.

Tykalová T, Rusz J, Švihlík J, Bancone S, Spezia A, Pellecchia MT. Speech disorder and vocal tremor in postural instability/gait difficulty and tremor dominant subtypes of Parkinson's disease. J Neural Transm. 2020;127:1295-1304.

Analyzing Wav2Vec 1.0 Embeddings for Cross-Database Parkinson's Disease Detection and Speech Features Extraction

Levodopa may modulate specific speech impairment in Parkinson's disease: an fMRI study

Computerized analysis of hypomimia and hypokinetic dysarthria for improved diagnosis of Parkinson's disease

Articulatory undershoot of vowels in isolated REM sleep behavior disorder and early Parkinson's disease